Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>Newly Diag+> > TREAT.: > USA. P. Glasdegib Tablets

---

USA. P. Glasdegib Tablets's subsections
(*) USA Approval Date: 2018. 11.21.
+Low-Dose Cytarabine CT
>adult patients who are ≥75 y
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 11.20
TradeMark
TradeMark Web-Site

USA. P. Glasdegib Tablets's products
This section has no products